Peter Dedon graduated with a B.A. in Chemistry from St. Olaf College in 1979 and obtained his M.D. and Ph.D. in Pharmacology from the University of Rochester in 1987. He pursued postdoctoral research in chromatin biology at the University of Rochester and studied the chemical biology of DNA-cleaving anticancer drugs at Harvard Medical School. In 1991, Dedon joined the MIT faculty and was instrumental in creating the Department of Biological Engineering in 1998. He currently serves as the Underwood Prescott Professor of Biological Engineering and is the Lead Principal Investigator of the Antimicrobial Resistance group associated with the SMART program. He is also a member of the MIT Center for Environmental Health Sciences. His research focuses on applying chemical approaches to understanding nucleic acid biology in the context of human disease, with significant advancements in epigenetics, epitranscriptomics, and genetic toxicology.
SMART Antimicrobial Resistance • Singapore-MIT Alliance
Lead research on antimicrobial resistance in collaboration with MIT and Singapore.
Massachusetts Institute of Technology • Cambridge, MA
Member of the faculty in the Department of Biological Engineering, focusing on nucleic acid biology and its applications.